Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

PROCEPT BioRobotics Corporation

PRCT
86,85
0,39 (0,45%)
11 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/12/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:36EDGAR2Form 144 - Report of proposed sale of securities
04/12/202422:10EDGAR2Form 144 - Report of proposed sale of securities
02/12/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202422:35EDGAR2Form 144 - Report of proposed sale of securities
26/11/202422:05GLOBEPROCEPT BioRobotics to Present at Upcoming 36th Annual Piper..
22/11/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:29EDGAR2Form 144 - Report of proposed sale of securities
15/11/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202422:23EDGAR2Form 144 - Report of proposed sale of securities
08/11/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:23EDGAR2Form 144 - Report of proposed sale of securities
31/10/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202421:02EDGAR2Form 8-K - Current report
30/10/202421:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/10/202401:43GLOBEPROCEPT BioRobotics Corporation Announces Pricing of..
28/10/202421:19GLOBEPROCEPT BioRobotics Corporation Announces Proposed Offering..
28/10/202421:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/10/202421:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/10/202412:03EDGAR2Form 8-K - Current report
28/10/202412:00GLOBEPROCEPT BioRobotics® Reports Third Quarter 2024 Financial..
28/10/202411:12IHMARKETNEWSUS Futures Rise; Oil Prices Drop Over 5% as Middle East..
17/10/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202422:04GLOBEPROCEPT BioRobotics to Report Third Quarter 2024 Financial..
07/10/202422:04GLOBEPROCEPT BioRobotics Received U.S. FDA Approval to Initiate..
18/9/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202423:47EDGAR2Form 144 - Report of proposed sale of securities
13/9/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202422:21EDGAR2Form 144 - Report of proposed sale of securities
28/8/202422:03GLOBEPROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo..
23/8/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202413:06EDGAR2Form 8-K - Current report
21/8/202413:00GLOBEPROCEPT BioRobotics Announces FDA Clearance of the HYDROS™..
02/8/202422:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202422:06EDGAR2Form 8-K - Current report
01/8/202422:03GLOBEPROCEPT BioRobotics® Reports Second Quarter 2024 Financial..
19/7/202423:24EDGAR2Form 8-K - Current report
15/7/202422:03GLOBEPROCEPT BioRobotics to Report Second Quarter 2024 Financial..
18/6/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:24EDGAR2Form 144 - Report of proposed sale of securities
17/6/202422:03GLOBEPROCEPT BioRobotics Announces New CPT® Category I Code from..
13/6/202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:59EDGAR2Form 144 - Report of proposed sale of securities
06/6/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:03GLOBEPROCEPT BioRobotics to Present at Upcoming 2024 Truist..
Apertura: 83,30 Min: 83,30 Max: 87,45
Chiusura: 86,46

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network